Price $25.28 |
Market Cap
2.97B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
15.1
|
P/B
2.91
|
P/S
0.47
|
Dividend %
3.30%
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-981K
|
FCF
-11.3
|
|
Op. Margin
2.40%
|
Net Margin
3.10%
|
ROE
19.90%
|
ROI
5.90%
|
|
ROA
7.20%
|
EPS Growth
28.00%
|
Current Ratio
1.7
|
Debt/Equity
46.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $2.58 | - | - | 152.2M | Strong Buy |
| Psychemedics Corp. (PMD) | $6.27 | - | 4.40% | 35.5M | Strong Buy |
| VolitionRX Ltd (VNRX) | $1.57 | - | - | 116.8M | Strong Buy |
| Voyager Therapeutics Inc (VYGR) | $5.57 | - | - | 258.8M | Strong Buy |
| Lineage Cell Therapeutics Inc (LCTX) | $1.18 | - | - | 285.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
